Riti Desai
Papers
1
Total Citations
12
H-Index
1
About
Dr. Riti Desai is a leading clinician-scientist whose research sits at the intersection of radiation oncology and ophthalmology, with a primary focus on neovascular age-related macular degeneration (nAMD). Her most significant contribution is her pivotal role in the STAR trial, a landmark, double-masked, sham-controlled study published in 2024 that investigated stereotactic radiotherapy as a novel treatment for nAMD. This work demonstrated that precisely targeted radiation can mitigate key pathogenic processes underlying the disease, offering a potential alternative to the standard-of-care anti-VEGF injections. The STAR trial, already garnering 12 citations shortly after publication, represents a paradigm shift in how we approach chronic retinal disease management. Dr. Desai’s research is distinguished by its rigorous, evidence-based approach to translating radiation biology into tangible patient benefits, addressing the critical unmet need for durable, less invasive therapies. Her work is not only highly cited but is also shaping clinical guidelines and inspiring a new generation of research into non-pharmacological interventions for blinding eye diseases.
Research Focus
Key Achievements
Top Papers
- 1